Maxim Group set a $8.00 price objective on BioLife Solutions (NASDAQ:BLFS) in a report issued on Thursday morning. The firm currently has a buy rating on the medical equipment provider’s stock.

Shares of BioLife Solutions (BLFS) traded up $0.14 on Thursday, reaching $6.03. 38,000 shares of the company traded hands, compared to its average volume of 71,150. The stock has a market cap of $81.92, a price-to-earnings ratio of -14.36 and a beta of 0.27. BioLife Solutions has a 12-month low of $1.66 and a 12-month high of $7.53.

BioLife Solutions (NASDAQ:BLFS) last issued its quarterly earnings data on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.03. The firm had revenue of $2.96 million for the quarter, compared to analyst estimates of $2.60 million. BioLife Solutions had a negative net margin of 52.10% and a negative return on equity of 49.92%. equities analysts predict that BioLife Solutions will post -0.23 EPS for the current year.

Institutional investors and hedge funds have recently modified their holdings of the stock. Essex Investment Management Co. LLC purchased a new stake in BioLife Solutions in the 3rd quarter valued at about $484,000. EAM Investors LLC purchased a new stake in BioLife Solutions in the 3rd quarter valued at about $555,000. Finally, Granite Investment Partners LLC purchased a new stake in BioLife Solutions in the 3rd quarter valued at about $1,205,000. Hedge funds and other institutional investors own 9.41% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/biolife-solutions-blfs-pt-set-at-8-00-by-maxim-group/1798600.html.

About BioLife Solutions

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with Analyst Ratings Network's FREE daily email newsletter.